EXTENDED REPORT

One year outcome of undifferentiated polyarthritis

L M A Jansen¹, D van Schaardenburg¹, I E van der Horst-Bruinsma², B A C Dijkmans²

¹ Jan van Breemen Instituut, Amsterdam, The Netherlands
² Department of Rheumatology, VU Medical Centre, Amsterdam, The Netherlands

Correspondence to:
Correspondence to:
Professor B A C Dijkmans, University Hospital Vrije Universiteit, Department of Rheumatology, PO Box 7057, 1007 MB Amsterdam, UK;
secr.reumatologie{at}vumc.nl

Objective: To identify variables that can predict a progressive outcome after one year of follow up in patients presenting with undifferentiated polyarthritis (UPA) at an early arthritis clinic.

Methods: New patients with arthritis in two or more joints of less than three years' duration were categorised at entry as UPA or as rheumatoid arthritis (RA) based on the clinical diagnosis of the rheumatologist. Outcome variables after one year were radiographic damage (Sharp/van der Heijde score) and functional status (Health Assessment Questionnaire: HAQ score). A progressive disease at one year was defined as radiographic progression 4, or one year radiographic damage 10, or HAQ score 1. The baseline variables of patients with UPA with a progressive or mild outcome were compared.

Results: 280 patients (70% women; median age 56 years (range 18–90), median duration of symptoms 3.5 months) were included. 203 (72%) patients were clinically diagnosed as having RA and 77 (27%) as having UPA. The group of patients with progressive UPA (n=32 (42%)) had a significantly higher mean age, prevalence of arthritis of the hands, and disease activity (DAS28) at the first visit compared with the patients of the mild UPA group (n=45 (58%)). The RA group had significantly more frequent serum IgM-RF positivity, higher mean disease activity (DAS28) and mean C reactive protein concentration, more frequent symmetric arthritis, and arthritis in more than three joint groups than the progressive UPA group. Six (19%) of the progressive UPA group versus eight (4%) of the RA group did not receive disease modifying antirheumatic drugs during the first year.

Conclusions: After one year of follow up, 32 (42%) of the patients with UPA had a progressive disease. A progressive outcome was associated with older age, higher disease activity, and arthritis of the hands at baseline. To avoid undertreatment of patients with UPA, treatment should be based on severity rather than on diagnosis.

Keywords: undifferentiated polyarthritis; prognosis; outcome

Abbreviations: ACR, American College of Rheumatology; CRP, serum C reactive protein; DAS28, disease activity score; DMARD, disease modifying antirheumatic drug; HAQ, Health Assessment Questionnaire; IgM-RF, serum rheumatoid factor; RA, rheumatoid arthritis; UPA, undifferentiated polyarthritis

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• MJAAVATTEN, M. D., HAUGEN, A. J., HELGETVEIT, K., NYGAARD, H., SIDENVALL, G., UHLIG, T., KVIEN, T. K. (2009). Pattern of Joint Involvement and Other Disease Characteristics in 634 Patients with Arthritis of Less Than 16 Weeks' Duration. The Journal of Rheumatology 36: 1401-1406 [Abstract] [Full Text]  
• Karim, Z., Quinn, M. A, Wakefield, R. J, Brown, A. K, Green, M. J, Hensor, E. M A, Conaghan, P. G, Emery, P. (2007). Response to intramuscular methyl prednisolone in inflammatory hand pain: evidence for a targeted clinical, ultrasonographic and therapeutic approach. Ann Rheum Dis 66: 690-692 [Abstract] [Full Text]